Albany, NY -- (SBWIRE) -- 11/07/2018 -- Global Pharyngitis Treatment Market: Overview
Pharyngitis is the medical condition that causes inflammation at the back of the throat which is known as pharynx. Pharyngitis is referred simply as sore throat. Pharyngitis may also lead to itchiness and difficulty in swallowing. There are several viral and bacterial agents that causes pharyngitis, majority of which includes measles, adenovirus, chickenpox, croup, whooping cough, and group A streptococcus. Pharyngitis is most commonly caused by viral infection such as common cold, influenza, and mononucleosis. Strep throat is one of the most common bacterial infection caused by group A streptococcus. The common symptoms of pharyngitis includes sneezing, runny nose, headache, cough, fatigue, body aches, chills, and fever. Strep throat condition may lead to difficulty in swallowing, loss of appetite, nausea, fever, loss of taste, and swollen lymph nodes.
Read Report Overview:https://www.transparencymarketresearch.com/pharyngitis-treatment-market.html
Global Pharyngitis Treatment Market: Drivers and Restraints
The global pharyngitis treatment market is projected to be driven by the high prevalence and growing incidence of flu worldwide. According to the American Osteopathic Association (AOA), pharyngitis induced sore throat in one of the leading reasons for physician visits in the United States. Viral infection such as common cold, influenza, and mononucleosis are some of the most common causes of sore throat. According to the World Health Organization, around 3-5 million cases of severe flu are recorded every year worldwide and between 2, 50,000 to 3, 00,000 deaths occur. The development of newer vaccines & medicines against flu, and government initiatives in various regions to promote awareness is likely to fuel the expansion of the global pharyngitis treatment market during the forecast period. Children between the age group 5 to 18 years are more likely to develop symptoms of pharyngitis than younger population. Self-medication for the treatment of pharyngitis such as use of antibiotics without knowing the exact cause (bacterial or viral infection) worsens the disease condition and may last for several days.
The global pharyngitis treatment market can be broadly categorized into four segments based on source of infection, by drug class, by distribution channel, and by region. In terms of source of pharyngitis infection, the global Pharyngitis treatment market can be segmented into viral and bacterial. The viral source is projected to account for prominent share in the global pharyngitis treatment market by the end of 2025. In terms of drug class, the Pharyngitis treatment market can be segmented into antiviral drugs, antibacterial drugs, anti-inflammatory drugs, and topical anesthetics drugs. Pharyngitis treatment market for antiviral drugs is projected to dominate the global market by the end of 2025 and the segment is projected to witness exponential growth rate during the forecast period 2017-2025. Amoxicillin and penicillin are the most commonly prescribed antibiotics for strep throat and are likely to hold the leading pharyngitis treatment market share in the antibacterial drug class segment. By distribution channel, the global pharyngitis treatment Market is segmented into hospital pharmacy, retail pharmacy, and online pharmacy.
Request Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=40919
Global Pharyngitis Treatment Market: Key Segments
Geographically, the global pharyngitis treatment market is segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe are projected to account for leading pharyngitis treatment market share by the end of 2025. The large share of North America and Europe is attributed to high prevalence and increasing incidence rate of flu and pharyngitis in these regions. Also, high adoption of influenza vaccines, high levels of awareness, and well established healthcare facilities etc. are projected to be key driving factors for the expansion of the pharyngitis treatment market in these regions. Pharyngitis treatment market in the Asia Pacific region is projected to witness exponential growth during the forecast period.
Global Pharyngitis Treatment Market: Key Players
Key players operating in the global pharyngitis treatment market include Genentech Inc., Adamas Pharmaceutical Inc., PLIVA HRVATSKA d.o.o., Pfizer Inc., Valeant Pharmaceuticals International, Inc., Mylan N.V., GSK group of companies, Teva Pharmaceutical Industries Ltd., AbbVie Inc., and others.
About Transparency Market Research
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/